Immunotherapy Thwarted by Mutational Load, Copy Loss Combo – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Immunotherapy Thwarted by Mutational Load, Copy Loss Combo
Genetic Engineering & Biotechnology News Immune checkpoint blockade, a therapy intended to boost the T-cell response to cancer, doesn't always work, for reasons that aren't always clear. If the reasons were better understood, this form of immunotherapy could become more effective. Ultimately … |
